What does Watson for Genomics do for your organization
Watson for Genomics enables molecular pathology laboratories to scale their precision oncology programs to meet the existing and growing needs of personalized cancer care. Watson for Genomics accomplishes this by leveraging AI to extract unstructured data from peer-reviewed literature to grow its knowledge base. It provides variant information and clinical content based on the updated approved therapeutic options (including targeted and immunotherapy options), professional guidelines, biomarker-based clinical trial options, genomic databases and relevant publications.
Benefits
Provide comprehensive clinical content
Access to expertly validated, comprehensive clinical content based on peer-reviewed publications, genomic databases, professional guidelines, clinical trials and approved therapies.
Save time & reduce reporting variablity
Designed to save time and reduce variability across reports with rapid, consistent, and efficient interpretation across cancer types.
Scale precision oncology programs
Easily scale sample volume and complexity of gene panel – targeted panels to whole genome.
Secure and privacy-compliant
Designed to comply with HIPAA and GDPR requirements.
Security and privacy in the cloud
When using IBM Cloud offerings, your company can scale and adapt quickly to changing business needs without compromising security, privacy or risk levels. Learn more about IBM Cloud security
This offering meets the following industry and global compliance standards, depending on the edition you choose.
- EU-US Privacy Shield and Swiss-US Privacy Shield Framework
- HIPAA for Healthcare USA
To learn about the compliance and certifications for a specific offering edition, consult the Cloud Services data security and privacy data sheets.
Product images
Testimonials
“ Molecular tumor boards empowered by cognitive computing can significantly improve patient care by providing a fast, cost-effective, and comprehensive approach for data analysis in the delivery of precision medicine. ”
- Associate Professor of Medicine and Genetics
- UNC Lineberger Comprehensive Cancer Center